Bristol Myers Squibb (BMY) has seen a recent upswing in its stock price, but it still lags behind the overall market. Here are some key facts to consider about the company....
Recently, the European Commission (EC) has given its approval to Breyanzi, a novel treatment developed by Bristol-Myers Squibb (BMS) for Non-Hodgkin's Lymphoma (NHL)....
Bristol-Myers Squibb Company's groundbreaking NHL treatment, Breyanzi, has received approval from the European Commission (EC) for its use in patients....
Bristol-Myers Squibb Company (BMY) has gained the attention of hedge funds as the best pharmaceutical stock to invest in....
Bristol-Myers Squibb Company (BMY) experienced a decline in their stock price on Friday. The decrease can be attributed to factors such as market volatility and investor sentiment....
Pfizer Inc. (NYSE:PFE), a world-renowned pharmaceutical company, has captured the attention of investors looking for steady dividends....
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has been gaining attention in the options market, leading to speculation of a potential spike in its stock....
Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....
AstraZeneca PLC (AZN) has made major strides in the global fight against COVID-19, leading to a significant rise in its share prices....
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has been a steady performer in the biopharmaceutical industry, delivering a decent return of 89% for investors over the last five years....